International Isotopes Revenue, Profits - INIS Quarterly Income Statement

Add to My Stocks
$0.08 $0 (0%) INIS stock closing price Jul 20, 2018 (Closing)

Fundamental analysis of INIS stock involves analyzing its financial statements, apart from checking the International Isotopes stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for INIS which shows a YOY revenue growth of 47.37% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the International Isotopes profit and loss statement for 2018 Q1 total to $1.1M. This line item shows that the operating expenses has decreased compared with last year. Also check: International Isotopes assets and International Isotopes free cash flow.

View and download details of revenue and profits for International Isotopes for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
International Isotopes Revenues or Net Sales
2.8M1.9M1.9M1.79M1.83M1.75M1.41M1.7M1.69M1.94M
Cost Of Goods Sold (COGS)1.44M1.02M1.05M1.09M1.02M----1.29M
International Isotopes Gross Profit
1.35M---------
Research & Development Expense----------
Selling General & Admin Expense1.1M1.15M1.32M1.09M1.36M1.12M----
Income Before Depreciation Depletion Amortization--0.37M-0.54M-0.47M-0.68M-0.42M-0.44M-0.35M-0.29M-0.48M
Depreciation Depletion Amortization----------
Non Operating Income--0.25M-0.93M-------
Interest Expense----------
International Isotopes Pretax Income
--0.76M-1.58M-0.59M-0.79M-0.54M-0.54M-0.44M-0.37M-0.56M
Provision for Income Taxes----------
MinorityInterest----0.01M--0.01M----0.01M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations--0.79M-1.58M-0.6M-0.79M-0.52M-0.54M-0.45M-0.38M-0.56M
Extraordinary Items & Discontinued Operations----------
International Isotopes Profit/ Loss (Net Income)
--0.79M-1.58M-0.6M-0.79M-0.52M-0.54M-0.45M-0.38M-0.56M
Average Shares used to compute Diluted EPS526.42M406.31M406.75M406.73M405.65M400M403.86M402.48M402.34M400.91M
Average Shares used to compute Basic EPS407.42M406.31M406.75M406.73M405.65M400M403.86M402.48M402.34M400.91M
Income Before Nonrecurring Items--0.79M-1.58M-0.6M-0.79M-0.52M-0.54M-0.45M-0.38M-0.56M
Income from Nonrecurring Items----------
International Isotopes Earnings Per Share Basic Net
0.000.000.000.000.000.000.000.000.000.00
International Isotopes Earnings Per Share Diluted Net
0.000.000.000.000.000.000.000.000.000.00
EPS Diluted Before Nonrecurring Items0.000.000.000.000.000.000.000.000.000.00
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Endocyte financial analysis

Before investing one should read a report on International Isotopes stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the International Isotopes revenue chart, as is the case with International Isotopes indicates a growing business. One needs to compare the QoQ topline or sales growth of INIS stock with its peers like STRN stock and CLIR stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: Most businesses like International Isotopes try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The INIS financials along with International Isotopes historical stock prices provide a lot of details about the firm.

International Isotopes Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.74
Operating Margin
5
Net Profit Margin
1.1
Dividend Yield
0%